Contract 36F79722D0166
Ascendis Pharma, Inc. · Department Of Veterans Affairs · September 29, 2023
Ascendis Pharma, Inc. was awarded a federal contract by Department Of Veterans Affairs on September 29, 2023 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 9 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 29, 2026. If all options are exercised, the contract could reach $59.85 million.
Contract details
- PIID
- 36F79722D0166
- Award type
- Fss
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 29, 2023
- Latest action
- June 29, 2026
Description
FSS
Modification timeline
-
June 29, 2026Mod P00017 · Supplemental Agreement For Work Within Scope$0
-
June 29, 2026Mod P00020 · Other Administrative Action$0
-
June 25, 2026Mod P00019 · Supplemental Agreement For Work Within Scope$0
-
May 26, 2026Mod P00018$0
-
February 4, 2026Mod P00015 · Supplemental Agreement For Work Within Scope$0
-
December 9, 2025Mod P00014 · Supplemental Agreement For Work Within ScopePL 2026 PRICE UPDATES$0
-
September 29, 2025Mod P00013 · Other Administrative Action$0
-
June 30, 2025Mod P00011 · Supplemental Agreement For Work Within Scope$0
-
June 26, 2025Mod P00012 · Other Administrative Action$0
-
September 29, 2023Mod P00004 · Other Administrative Action$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79722D0166?
Contract 36F79722D0166 is a federal contract awarded to Ascendis Pharma, Inc. by Department Of Veterans Affairs on September 29, 2023 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 9 times since the base award.
Who won contract 36F79722D0166?
Ascendis Pharma, Inc. won contract 36F79722D0166 from Department Of Veterans Affairs.
How much is contract 36F79722D0166 worth?
Contract 36F79722D0166 has obligated $0 to date but carries a potential ceiling of $59.85 million if fully funded and all options are exercised.